Overview

Corning Incorporated (NYSE: GLW) announced that it has completed the acquisition of Mediatech, Inc., a Virginia-based corporation, including Mediatech’ s subsidiary, KD Medical, a Maryland-based corporation.

Mediatech develops, manufactures, and sells a broad range of high-quality cell culture media and molecular biology reagents related to tissue and cell culture applications.

Mediatech will be integrated into Corning’s Life Sciences segment.

Significance

Mediatech’ s wide array of culture media and molecular biology reagents are complementary to the general labware, cell culture, lab equipment, and HTS/Assay products offered today by Corning.

This acquisition enables Corning to continue to improve its strategic balance by strengthening its Life Sciences segment.

Mediatech’ s leading cellgro® brand which includes basal salt solutions, antibiotics, and flexibility packaging systems, will be leveraged by Corning to supply its customers with a more comprehensive line of laboratory research tools than previously offered.

Crosstree’s Role

Crosstree Capital Partners served as exclusive financial advisor to Mediatech.

Crosstree ran a highly-targeted process, managing interest from several large strategic buyers.

The transaction represents a successful outcome for Mediatech’ s founders, including CEO Jim DeOlden, and investors, Great Point Partners.